These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 10571260)

  • 1. Analysis of the anti-HIV-1 activity of an anti-p17-derivative peptide (P30-52) monoclonal antibody.
    Ota A; Ueda S
    Hybridoma; 1999 Aug; 18(4):305-14. PubMed ID: 10571260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory mechanism of anti-P30-52 monoclonal antibody against human immunodeficiency virus type 1 (HIV-1) multiplication in infected MT-4 cells.
    Ota A; Ueda S
    Hybridoma; 1999 Jun; 18(3):235-41. PubMed ID: 10475237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-P30-52 monoclonal antibody cross-reacted to Env V3 and inhibited the viral multiplication of HIV-1-infected MT-4 cells.
    Ota A; Bautista AN; Yadav ML; Ueda S
    Hybridoma; 1999 Apr; 18(2):139-47. PubMed ID: 10380013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-reactivity of anti-HIV-1-p17-derivative peptide (P30-52) antibody to Env V3 peptide.
    Ota A; Tanaka-Taya K; Ueda S
    Hybridoma; 1999 Apr; 18(2):149-57. PubMed ID: 10380014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Random expression of human immunodeficiency virus-1 (HIV-1) p17 (epitopes) on the surface of the HIV-1-infected cell.
    Ota A; Liu X; Fujio H; Sakato N; Ueda S
    Hybridoma; 1998 Feb; 17(1):73-5. PubMed ID: 9523241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. cDNA encoding a single-chain antibody to HIV p17 with cytoplasmic or nuclear retention signals inhibits HIV-1 replication.
    Tewari D; Goldstein SL; Notkins AL; Zhou P
    J Immunol; 1998 Sep; 161(5):2642-7. PubMed ID: 9725267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutralization of human immunodeficiency virus type 1 (HIV-1) with antibody from carriers' plasma against HIV-1 protein p17.
    Kageyama S; Katsumoto T; Taniguchi K; Ismail SI; Shimmen T; Sasao F; Gao M; Owatari S; Wakamiya N; Tsuchie H; Ueda S; Shiraki K; Kurimura T
    Acta Virol; 1996 Sep; 40(4):195-200. PubMed ID: 9014009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV Gag p17 protein impairs proliferation of normal lymphocytes in vitro.
    Hofmann B; Nishanian P; Fan J; Nguyen T; Fahey JL
    AIDS; 1994 Jul; 8(7):1016-7. PubMed ID: 7946090
    [No Abstract]   [Full Text] [Related]  

  • 9. Characterization of murine monoclonal antibodies directed against the submembrane protein p17 of HIV-1.
    Niedrig M; Harthus HP; Bröker M; Meloen R; Gelderblom H; Pauli G
    Hybridoma; 1993 Aug; 12(4):431-9. PubMed ID: 7503941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical studies on immunogenicity of the HIV-1 p17-based synthetic peptide AT20-KLH.
    Fiorentini S; Marini E; Bozzo L; Trainini L; Saadoune L; Avolio M; Pontillo A; Bonfanti C; Sarmientos P; Caruso A
    Biopolymers; 2004; 76(4):334-43. PubMed ID: 15386266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recognition of two overlapping CTL epitopes in HIV-1 p17 by CTL from a long-term nonprogressing HIV-1-infected individual.
    Harrer T; Harrer E; Barbosa P; Kaufmann F; Wagner R; Brüggemann S; Kalden JR; Feinberg M; Johnson RP; Buchbinder S; Walker BD
    J Immunol; 1998 Nov; 161(9):4875-81. PubMed ID: 9794421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of cellular and humoral immune responses to human immunodeficiency virus type 1 Gag and Pol by a G/P-92 fusion protein expressing highly immunogenic Gag p17/p24 and Pol p51 antigens.
    Kmieciak D; Bolesta E; Naito T; Gzyl J; Kaneko Y; Kozbor D
    J Hum Virol; 2001; 4(6):306-16. PubMed ID: 12082397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of monoclonal antibodies against the human immunodeficiency virus matrix protein, p17gag: identification of epitopes exposed at the surfaces of infected cells.
    Shang F; Huang H; Revesz K; Chen HC; Herz R; Pinter A
    J Virol; 1991 Sep; 65(9):4798-804. PubMed ID: 1714518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of HIV-1 replication in primary human T cells transduced with an intracellular anti-HIV-1 p17 antibody gene.
    Tewari D; Notkins AL; Zhou P
    J Gene Med; 2003 Mar; 5(3):182-9. PubMed ID: 12666184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of monoclonal antibodies identifying type and strain-specific epitopes of human immunodeficiency virus type 1.
    Robert V; Resnicoff M; Chermann JC; Devaux C
    Mol Cell Biochem; 1991 Apr; 102(2):115-23. PubMed ID: 1715507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three antigenic regions in p17 of human immunodeficiency virus type 1 (HIV-1) revealed by mouse monoclonal antibodies and human antibodies in HIV-1 carrier sera.
    Liu X; Ota A; Watanabe M; Ueda S; Saitoh A; Shinagawa H; Nakata A; Kurimura T; Wang X; Zhao Y
    Microbiol Immunol; 1995; 39(10):775-85. PubMed ID: 8577268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of large glycosylated proteins recognized by monoclonal antibodies against HIV-1 gag proteins.
    Pinter A; Honnen WJ; Revesz K; Herz R
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1341-4. PubMed ID: 1466953
    [No Abstract]   [Full Text] [Related]  

  • 18. Antibody recognition of synthetic peptides mimicking immunodominant regions of HIV-1 p24 and p17 proteins.
    Lottersberger J; Salvetti JL; Beltramini LM; Tonarelli G
    Rev Argent Microbiol; 2004; 36(4):151-7. PubMed ID: 15786866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1 matrix protein p17 modulates in vivo preactivated murine T-cell response and enhances the induction of systemic and mucosal immunity against intranasally co-administered antigens.
    Fiorentini S; Becker PD; Marini E; Marconi P; Avolio M; Tosti G; Link C; Manservigi R; Guzman CA; Caruso A
    Viral Immunol; 2006; 19(2):177-88. PubMed ID: 16817760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p17 and p17-containing gag precursors of input human immunodeficiency virus are transported into the nuclei of infected cells.
    Sharova N; Bukrinskaya A
    AIDS Res Hum Retroviruses; 1991 Mar; 7(3):303-6. PubMed ID: 2064827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.